Business Transformation
Navigating the U.S. CDMO Industry
Emerging Realities and Strategic Considerations
The postpandemic belief that CDMOs would retain lasting pricing power has faded The discussion at a major healthcare
US Biosimilar Market Current Trends & Challenges
The Biologics Price Competition and Innovation Act BPCIA enacted on March was created to set up
Resilient by Design
GxP Compliance and Supply Chain Innovation in the Post-Pandemic Era
The COVID pandemic served as a powerful stress test for the pharmaceutical industry It disrupted manufacturing lines
Rethinking Evidence Strategy in HEOR Budget Planning
Health economics and outcomes research HEOR can no longer be approached as a oneanddone cookiecutter process
Driving Biotech Innovation
Navigating Fast-to-Clinic and Fast-to-Market Strategies from Discovery to Commercialization
In the dynamic landscape of pharmaceutical research small to mediumsized biotech firms many of which operate virtually
A Ǫuick start Guide for Successful Cloud Migration of Global Pharmacovigilance (GPV) IT Applications
In the everevolving regulatory landscape of Global Pharmacovigilance GPV
